Expert Pitch
University of Alabama at Birmingham

Expert available to comment on Trump's executive order regarding kidney disease and donations

On Wednesday, President Trump signed an executive order signaling new measures that could overhaul treatment for kidney disease, donations and kidney transplants.

As one of the premier transplant centers in the Southeast, UAB Hospital treats a high volume of patients with kidney disease, including patients on dialysis. 

Chris Meeks, director of Legacy of Hope (formerly Alabama Organ Center) is available to provide additional comments on what this means for organ procurement. 

Meeks outlines a few points from Trump's announcement:

1. Chronic kidney disease significantly impacts the people of Alabama which makes Legacy of Hope’s mission, to end the wait and suffering by shepherding the gift of life to those in needs of organ and tissue transplant, even more important.

2. Seventy percent of Alabama’s kidney transplant waiting list is African American. While the need is great in the African American community the authorization rate for donation is 43 percent, significantly lower than the Caucasian authorization rate of 70 percent. The donor registry rates in the African Community are lower as well. In an effort to more effectively educate the African American community, Legacy of Hope has a dedicated Multicultural Educator.

3. Legacy of Hope is working diligently to increase the number of organs available for transplant. As a result of our alliances with hospitals and the community, Legacy of Hope has provided more organs for transplant than ever before, 87 percent growth since 2012. There has been enormous growth in the number of organ donors, 68 percent since 2012.

4. Currently, 38 percent of licensed drivers are registered donors. The registry is growing by 9,000 citizens a month because of Legacy of Hope’s public education efforts and the generosity of the citizens of Alabama.

5. Legacy of Hope is supportive of aligning the organ procurement organization’s performance metrics with those of transplant hospitals. This will increase the number of organs available for transplant. Legacy of Hope also supports better metrics because organ donation has changed over time and the metrics should change too.


Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

Showing results

110 of 4573